BEIJING: Researchers at Shanghai-based Huashan Hospital of Fudan University have identified a new blood biomarker that may help doctors diagnose Alzheimer's disease early.
Through a study involving more than 800 participants, the researchers found that plasma glial fibrillary acidic protein (GFAP) was significantly higher in blood samples from those with Alzheimer's than those without.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.